Investors, entrepreneurs, psychedelic researchers, environmentalists, tech experts, medical & science specialists, and health professionals, are invited to attend the Microdose Psychedelic Capital Conference on May 26, 2022 as an online event.
Microdose is a premier global psychedelic network group. It is focused on growing the psychedelic industry and driving it to the forefront of modern medicine by sharing valuable content, organising networking events, analysing reports, and offering the latest news and strategies.
The virtual conference is a robust psychedelic platform that offers exposure to psychedelic dedicated ventures that are trying to carve a niche for themselves. Businesses can showcase their products and skills to avail the phenomenal investor opportunities available at this forum. Enthusiasts and capitalists looking for investment opportunities can discover the untapped potential to develop, launch and market novel psychedelic supplies in the market.
The agenda of the conference will include discussions, keynotes, and insights from world-class speakers, top companies, latest IPOs about the potential and scope of investments in the psychedelic sector.
The Microdose conference will explore pre-IPO opportunities in the psychedelic investment sector. Thought leaders, influencers, and entrepreneurs attending the conference will share insights and discuss the latest innovations in drug development, and the financial, scientific, and industrial news in the psychedelic world. Learn about the laws and regulations and current business trends driving the psychedelic industry.
A part of the bi-monthly investor series, this virtual Microdose Conference explores the new technologies driving the industry, the scope of psychedelic investments and the prospects. It offers a forum to connect businesses to the top capitalists and investors of the psychedelic spectrum. These online sessions offer tremendous networking scope where businesses build strong ties and associations.
Many global leaders of the psychedelic spectrum will reside as speakers to share their views, announce new products and impart insights into the future trends of this industry.
The introduction of the Microdose event will be given by:
- Patrick Moher, the President of Microdose Psychedelics Insights, is a dynamic entrepreneur working on creating innovative business opportunities in psychedelic industries, across the social and economic spectrum for upcoming industries.
- Richard Skaife, Chair, Microdose, The Conscious Fund, a veteran in mental health, technology and investment, accredited with the multi-million downloaded Digipill app.
Microdose Psychedelic Capital Conference recordings are accessible to ticket holders for a lifetime. Every company’s pitch deck is also available for viewing and access by ticket holders.
To learn more, please visit https://ibn.fm/Ii1VO.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.